INM
INM
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
10
$1.36M
Insider Sales
0
$0
Total Volume
$1.36M
20 transactions
Net Activity
+$1.36M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$736.71B total
Adar1 Capital Management, LLC
10%
$927K total
Vivo Opportunity, LLC
10%
$434K total
Quick Actions
INM has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at INM (INM) engaged in a total of 20 transactions reported via SEC Form 4 filings. Among these, 10 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.36M.
The net insider activity for INM shows a net buying bias of $1.36M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 800.0K shares valued at $374.84B on May 19, 2026.
INM Stock Alert: What to Know as InMed, Mentari Announce Merger
MTRI - Mentari Therapeutics Inc Stock Price and Quote
97.295% of votes approved issuing shares for a merger subject to closing conditions.
InMed and Mentari announce all-stock merger deal (INM:NASDAQ)
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
IBM is the latest AI casualty. Shares tank 13% on Anthropic programming language threat
FAQs About INM Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for INM.